≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Disorders of lacrimal system and orbit in diseases classified elsewhere

DOID Endpoint Browser

H7_LACRIMALORBITINOTH

eye disease: A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma. [NCIt:C26767]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H06*
  • Cause of death: ICD-10 — H06*

2 out of 7 registries used, show all original rules.

912

4. Check minimum number of events

None

912

5. Include endpoints

None

912

6. Filter based on genotype QC (FinnGen only)

912

Control definitions (FinnGen only)

Control exclude
H7_LIDLACRIMALORBIT

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 912 747 165
Unadjusted period prevalence (%) 0.22 0.25 0.07
Median age at first event (years) 52.25 51.81 54.22

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
811
Matched controls
8108
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
323.0
677
*
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
497.7
323.0
692
92
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
79.6
323.0
417
106
H03BB01
ATC
carbimazole; oral
171.6
323.0
628
158
H03AA01
ATC
levothyroxine sodium; systemic
20.7
304.3
658
1392
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
+∞
276.3
249
*
BAA60
NOMESCO Finland
Total thyroidectomy
50.9
230.7
278
82
H062, E050
ICD-10 Finland
NA
+∞
213.2
195
*
104
Kela drug reimbursment
Thyroid insufficiency
15.1
171.0
310
318
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
58.2
167.2
196
44
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
7.7
149.5
618
2381
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
259.3
111.8
112
5
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
51.1
101.5
122
28
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.9
95.9
477
1837
H05.2
ICD-10 Finland
Exophthalmic conditions
+∞
93.6
88
*
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
57.0
92.6
109
22
C07AA05
ATC
propranolol; systemic
5.0
85.2
348
1054
H53.2
ICD-10 Finland
Diplopia
18.4
82.0
130
83
H04.10
ICD-10 Finland
Dry eye syndrome
9.9
71.2
152
185
H50.2
ICD-10 Finland
Vertical strabismus
54.5
66.7
79
16
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
63.4
64.9
75
13
XCW99
NOMESCO Finland
Other investigative procedure of eye
6.3
64.4
190
375
H02AB06
ATC
prednisolone; systemic
3.4
59.1
512
2719
XCK00
NOMESCO Finland
Perimetry
7.8
58.2
143
216
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
+∞
50.5
48
*
H02.3
ICD-10 Finland
Blepharochalasis
49.0
45.7
55
12
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.8
44.0
221
731
ZX120
NOMESCO Finland
Intravenous
4.7
41.5
157
397
ZXA10
NOMESCO Finland
Bilateral
3.3
36.3
218
814
CEC00
NOMESCO Finland
Recession of extraocular muscle
61.5
35.5
41
7
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.5
34.6
109
223
CAC44
NOMESCO Finland
Combined decompression of orbit
+∞
34.6
33
*
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
+∞
34.6
33
*
CA1AD
NOMESCO Finland
Orbita CT
66.3
33.3
38
6
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.5
33.2
178
604
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
13.8
32.9
57
44
H50.6
ICD-10 Finland
Mechanical strabismus
+∞
32.5
31
*
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
11.9
30.3
56
50
H50.0
ICD-10 Finland
Convergent concomitant strabismus
34.0
30.2
39
12
A02BC02
ATC
pantoprazole; systemic
2.5
29.9
590
4220
E03.89
ICD-10 Finland
Other specified hypothyroidism
6.6
29.9
80
133
T85
ICPC
Hyperthyroidism/thyrotoxicosis
46.9
29.9
36
8
H50.8
ICD-10 Finland
Other specified strabismus
155.5
28.8
30
*
WF099
NOMESCO Finland
Other radiotherapy
36.5
27.6
35
10
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
26.8
217
961
CAC20
NOMESCO Finland
Lateral decompression of orbit
+∞
26.2
25
*
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
+∞
26.2
25
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
8.4
25.6
57
72
T86
ICPC
Hypothyroidism/myxoedema
5.5
25.3
78
155
H02.5
ICD-10 Finland
Other disorders affecting eyelid function
+∞
25.1
24
*
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
93.0
24.8
27
*
H02AB07
ATC
prednisone; oral
2.9
23.4
163
653
2AB04
NOMESCO Finland
NA
67.0
22.9
26
*
H02.4
ICD-10 Finland
Ptosis of eyelid
33.3
22.5
29
9
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.3
22.5
124
422
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
12.0
20.9
38
33
XCK10
NOMESCO Finland
Photography of fundus of eye
3.3
20.1
108
360
C07AB07
ATC
bisoprolol; oral
2.0
19.7
391
2569
CEW99
NOMESCO Finland
Other operation on extraocular muscle
204.7
19.6
20
*
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
23.2
19.2
27
12
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.2
19.1
61
126
E03
ICD-10 Finland
Other hypothyroidism
3.6
19.1
91
276
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
18.1
247
1382
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
27.4
17.9
24
9
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
97.2
17.6
19
*
E05.5
ICD-10 Finland
Thyroid crisis or storm
183.8
17.6
18
*
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
35.9
16.7
21
6
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
+∞
16.7
16
*
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
173.4
16.6
17
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
16.3
340
2226
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.0
16.0
279
1707
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.2
15.9
50
102
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
+∞
15.7
15
*
CBB20
NOMESCO Finland
Correction of lax skin of eyelid and resection of herniated fat
+∞
15.7
15
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.7
15.6
53
118
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.0
15.0
90
322
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
11.6
14.9
27
24
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
16.9
14.8
23
14
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
152.6
14.5
15
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.4
14.0
68
210
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.4
13.9
69
216
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
76.4
13.6
15
*
E05.89
ICD-10 Finland
Other thyrotoxicosis
34.7
13.5
17
5
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
13.1
13.5
23
18
A11CC03
ATC
alfacalcidol; systemic
6.7
13.2
33
51
H57.1
ICD-10 Finland
Ocular pain
5.0
13.2
42
88
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
32.6
12.6
16
5
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
+∞
12.5
12
*
N05CF01
ATC
zopiclone; oral
1.8
12.5
272
1766
H01.0
ICD-10 Finland
Blepharitis
3.8
12.2
51
140
S01GX01
ATC
cromoglicic acid; ophthalmic
2.0
12.0
184
1054
H03BA02
ATC
propylthiouracil; oral
65.9
11.6
13
*
WX002
NOMESCO Finland
Sedation and analgesia
2.0
11.6
161
884
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
6.0
11.6
31
53
CS494
NOMESCO Finland
Other visual field testing
5.3
11.5
34
66
CBB21
NOMESCO Finland
Correction of lax skin and resection of herniated fat in upper eyelid
121.6
11.5
12
*
CE2W4
NOMESCO Finland
Eye movement mapping
43.9
10.9
13
*
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
18.1
10.8
16
9
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
28.4
10.7
14
5
WF002
NOMESCO Finland
Radical radiotherapy
3.8
10.7
44
119
CA1BD
NOMESCO Finland
Extensive orbita CT
+∞
10.4
10
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
12.2
10.4
18
15
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
19.1
10.3
15
8
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
4.4
10.2
36
85
1XC02
NOMESCO Finland
NA
10.2
10.0
19
19
E83.51
ICD-10 Finland
Hypocalcemia
26.4
9.8
13
5
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
20.3
9.8
14
7
106
Kela drug reimbursment
Hypoparathyroidism
13.6
9.7
16
12
H40.0
ICD-10 Finland
Glaucoma suspect
2.7
9.4
66
260
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.9
9.3
137
769
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
5.6
9.3
26
48
WX402
NOMESCO Finland
General anaesthesia
1.9
9.2
140
796
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
11.6
9.1
16
14
S01KA02
ATC
hypromellose; ophthalmic
5.0
8.9
27
55
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
8.7
8.8
18
21
CB9S4
NOMESCO Finland
Photography of eyelids and eyebrows
50.5
8.7
10
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
10.2
8.5
16
16
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
27.8
8.5
11
*
H02.1
ICD-10 Finland
Ectropion of eyelid
90.9
8.4
9
*
CD2S4
NOMESCO Finland
Photography of eye
17.4
8.1
12
7
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.5
7.9
61
257
A11CC02
ATC
dihydrotachysterol; oral
13.2
7.9
13
10
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.6
7.9
57
231
H50.1
ICD-10 Finland
Divergent concomitant strabismus
10.9
7.8
14
13
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
6.8
7.6
18
27
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
25.3
7.6
10
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.7
7.4
31
87
H02AB09
ATC
hydrocortisone; systemic
4.0
7.4
28
72
ZXA00
NOMESCO Finland
Right side
1.6
7.3
199
1346
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
11.0
7.3
13
12
E50.0
ICD-10 Finland
Vitamin A deficiency with conjunctival xerosis
+∞
7.3
7
*
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
+∞
7.3
7
*
CBD99
NOMESCO Finland
Other plastic reconstruction of eyelid
+∞
7.3
7
*
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
+∞
7.3
7
*
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
7.3
7
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
7.2
175
1146
ZXC95
NOMESCO Finland
Use of surgical navigator
6.1
7.1
18
30
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
7.1
92
490
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.7
6.9
22
48
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
6.9
83
429
S01EE01
ATC
latanoprost; ophthalmic
2.6
6.9
46
180
N07BA03
ATC
varenicline; oral
2.6
6.9
48
192
XCH00
NOMESCO Finland
Eye pressure measurement
3.0
6.9
37
127
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
16.8
6.8
10
6
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
16.8
6.8
10
6
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
6.5
70
348
H52.2
ICD-10 Finland
Astigmatism
5.8
6.5
17
30
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.1
6.4
75
383
H01CB02
ATC
octreotide; parenteral
14.4
6.4
10
7
H50.30
ICD-10 Finland
Intermittent esotropy
14.4
6.4
10
7
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.5
6.4
48
200
WX140
NOMESCO Finland
Parabulbar anesthesy
2.9
6.3
36
127
H02.8
ICD-10 Finland
Other specified disorders of eyelid
18.2
6.3
9
5
G73.0*E05.9
ICD-10 Finland
Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]
+∞
6.3
6
*
H05.1
ICD-10 Finland
Chronic inflammatory disorders of orbit
+∞
6.3
6
*
H05.0
ICD-10 Finland
Acute inflammation of orbit
+∞
6.3
6
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
26.9
6.2
8
*
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.7
6.2
38
143

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
443
511
15.91
307.65
7.7
3.2
pmol/l
4.6
4.5
0.10
419
450
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
457
200
44.80
307.65
5.1
1.7
iu/l
6.0
4.8
0.68
322
70
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
885
6335
14.41
68.92
14.7
4.2
pmol/l
15.8
14.7
34.82
852
5808
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
201
624
3.85
55.96
1.4
1.2
iu/ml
232.5
155.1
1.56
88
253
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
577
3632
2.60
41.66
7.1
6.0
mmol/l
1.2
1.2
1.57
492
3051
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
889
7329
9.45
36.56
16.1
4.9
mu/l
1.6
2.1
1.86
859
6746
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
522
3293
2.37
35.11
6.1
5.2
mmol/l
1.2
1.2
1.68
488
2961
(3013650) Neutrophils [#/volume] in Blood by Automated count
631
4430
2.38
31.60
8.9
8.6
e9/l
3.8
4.0
0.85
552
3878
(3018418) pH of Serum or Plasma
378
2152
2.29
31.39
4.5
3.6
ph
7.4
7.4
2.15
70
405
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
151
568
2.99
29.69
2.8
3.5
ng/l
52.4
80.6
9.99
136
509
(3015377) Calcium [Moles/volume] in Serum or Plasma
420
2546
2.20
29.41
3.2
3.3
mmol/l
2.3
2.4
3.97
372
2228
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
497
3295
2.12
26.80
2.7
2.3
nmol/l
77.6
78.0
0.13
458
2969
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
740
5896
2.35
22.81
8.4
6.9
u/l
76.4
77.0
0.15
716
5525
(3002030) Lymphocytes/100 leukocytes in Blood
519
3631
2.00
22.64
5.7
5.5
%
28.6
28.7
0.05
490
3364
(3022096) Basophils/100 leukocytes in Blood
494
3400
1.99
22.56
5.7
5.5
%
0.7
0.7
0.49
463
3147
(3019069) Monocytes/100 leukocytes in Blood
507
3534
1.98
22.17
5.9
5.7
%
8.5
8.3
0.93
479
3294
(3006504) Eosinophils/100 leukocytes in Blood
505
3520
1.97
22.03
5.7
5.4
%
2.9
2.8
0.54
474
3257
(3018010) Neutrophils/100 leukocytes in Blood
510
3591
1.95
21.33
5.6
5.3
%
56.3
56.8
0.46
482
3342
(42870588) Differential panel, method unspecified - Blood
381
2457
1.95
20.45
5.5
5.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
541
3930
1.93
20.12
5.9
5.6
e9/l
0.2
0.2
0.84
468
3456
(3019198) Lymphocytes [#/volume] in Blood
535
3873
1.92
20.10
5.7
5.3
e9/l
1.9
1.9
0.60
470
3414
(3001604) Monocytes [#/volume] in Blood
522
3762
1.91
19.73
5.7
5.3
e9/l
0.6
0.6
0.09
449
3254
(40758558) Short blood count panel - Blood
314
1924
1.96
19.37
7.1
6.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
522
3779
1.89
19.28
5.7
5.4
e9/l
0.0
0.0
0.42
447
3271
(3036481) Cortisol [Moles/volume] in Serum or Plasma
150
693
2.39
19.13
2.4
2.0
nmol/l
368.3
375.5
0.18
139
641
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
46
123
3.89
15.38
1.7
2.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
695
5717
1.91
15.15
4.7
3.9
mm/h
11.7
11.9
0.21
655
5279
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
35
82
4.40
13.93
3.6
5.0
u/ml
49.9
61.3
—
9
25
(3013826) Glucose [Moles/volume] in Serum or Plasma
541
4227
1.69
13.01
4.4
4.1
mmol/l
6.4
6.6
1.07
509
3923
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
403
2919
1.68
12.92
2.1
1.9
pmol/l
99.0
96.8
0.38
199
1458
(3023103) Potassium [Moles/volume] in Serum or Plasma
870
7956
3.03
12.12
16.6
13.5
mmol/l
3.9
3.9
2.34
853
7715
(3019550) Sodium [Moles/volume] in Serum or Plasma
868
7929
2.96
12.11
16.4
13.5
mmol/l
139.8
139.7
0.62
853
7702
(3037522) Nuclear Ab [Titer] in Serum
181
1063
1.88
11.91
1.4
1.3
titre
361.1
524.2
1.17
38
238
(3024561) Albumin [Mass/volume] in Serum or Plasma
411
3071
1.62
11.15
4.1
4.2
g/l
35.9
35.9
0.07
383
2877
(3021589) Normoblasts [#/volume] in Blood
444
3389
1.60
10.96
9.9
8.5
e9/l
0.0
0.0
0.45
357
2773
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
848
7727
2.39
10.68
13.7
12.1
mg/l
21.5
21.2
0.09
670
5969
(3007164) IgA [Mass/volume] in Serum or Plasma
238
1562
1.71
10.64
1.5
1.4
g/l
2.2
2.3
0.81
131
948
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
796
7100
1.95
10.36
6.0
5.3
mmol/mol
39.0
39.3
0.39
751
6581
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
268
1828
1.66
10.31
1.4
1.2
u/ml
1.2
1.7
0.46
67
468
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
830
7542
2.12
9.79
5.0
4.3
mmol/l
5.9
5.8
0.06
786
6896
(3052851) Hemolysis interference index of Serum or Plasma
50
200
2.59
8.61
2.2
3.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
118
670
1.87
8.49
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
199
1314
1.66
8.48
2.9
2.8
mmol/l
2.4
2.4
1.56
169
1154
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
881
8288
2.85
8.22
13.7
9.6
u/l
23.9
25.0
1.73
866
7997
(3035637) Corticotropin [Mass/volume] in Plasma
26
74
3.59
8.01
2.0
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
45
178
2.61
7.94
1.2
1.2
u/ml
60.8
47.2
—
6
20
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
21
52
4.11
7.83
1.1
1.1
nmol/l
1.3
0.3
—
6
8
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
188
1247
1.64
7.82
4.2
3.3
ng/l
233.4
341.2
0.25
142
885
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
806
7366
1.81
7.65
13.6
11.2
ml/min/173m2
83.8
82.6
0.93
696
6022
(3001019) Free T4 and TSH panel - Serum or Plasma
96
527
1.92
7.65
2.2
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
607
5191
1.51
7.63
3.4
2.9
u/l
36.6
44.1
2.56
580
4851
(3021879) Hepatitis B virus core Ab [Presence] in Serum
95
531
1.88
7.17
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
133
823
1.72
7.16
1.4
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
326
2504
1.47
6.85
3.8
3.4
e6/l
61.9
92.2
0.71
213
1717
(3030467) Casts [#/volume] in Urine by Automated count
261
1918
1.51
6.83
3.0
2.8
e6/l
0.3
0.4
0.95
190
1419
(3026782) Osmolality of Urine
194
1337
1.57
6.81
2.8
2.4
mosm/kgh2o
545.4
536.1
0.22
154
1142
(3012095) Magnesium [Moles/volume] in Serum or Plasma
167
1117
1.61
6.64
3.3
3.0
mmol/l
0.8
0.8
0.01
150
1045
(3044640) Blood type and Crossmatch panel - Blood
306
2342
1.46
6.48
2.2
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
612
5334
1.45
6.28
3.7
3.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
28
102
2.80
5.83
1.1
1.3
—
58.6
—
0
6
(36304419) Bacteria [Presence] in Urine
252
1893
1.46
5.77
3.1
2.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
721
6530
1.50
5.71
21.1
14.9
%
13.6
13.7
0.82
714
6392
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
318
2501
1.42
5.65
3.3
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
164
1135
1.54
5.58
1.4
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
595
5215
1.41
5.51
4.6
4.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
18
52
3.51
5.47
5.8
7.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
155
1064
1.55
5.46
2.8
2.7
e6/l
4.3
3.6
0.23
82
536
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
236
1769
1.45
5.42
2.6
2.1
mg/l
2.6
3.1
3.22
210
1496
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
236
1781
1.44
5.20
2.2
2.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
241
1829
1.43
5.15
4.1
3.4
%
93.1
95.6
0.84
236
1779
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
50
253
2.03
5.08
1.9
2.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
131
881
1.57
5.05
4.6
4.6
mmol/l
1.1
1.0
0.37
115
811
(3001122) Ferritin [Mass/volume] in Serum or Plasma
411
3447
1.35
4.70
3.5
2.7
ug/l
91.0
102.9
0.86
380
3199
(3007461) Platelets [#/volume] in Blood
894
8642
2.75
4.69
25.3
18.2
e9/l
262.1
258.7
0.93
874
8430
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
78
469
1.73
4.67
2.7
2.7
ng/l
150.2
160.8
0.11
70
434
(3024731) MCV [Entitic volume]
894
8647
2.72
4.59
25.2
18.2
fl
91.0
90.9
0.39
887
8524
(3035941) MCH [Entitic mass]
894
8648
2.71
4.57
25.2
18.1
pg
30.2
30.2
0.21
887
8524
(3026361) Erythrocytes [#/volume] in Blood
894
8649
2.70
4.55
25.3
18.2
e12/l
4.5
4.5
2.63
872
8412
(3010813) Leukocytes [#/volume] in Blood
894
8651
2.69
4.51
25.3
18.3
e9/l
6.6
6.6
0.00
873
8411
(40768804) Tissue Pathology biopsy report
390
3260
1.34
4.50
2.1
2.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
894
8652
2.69
4.49
25.4
18.3
g/l
135.3
134.0
2.49
888
8526
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
102
665
1.60
4.48
2.2
2.2
u/l
28.2
39.5
2.24
86
561
(3002582) Erythrocytes [#/volume] in Urine
266
2097
1.38
4.47
3.2
2.9
e6/l
36.3
56.2
0.50
194
1579
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
159
1148
1.47
4.37
2.7
2.5
e6/l
1.9
1.3
0.45
86
617
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
455
3907
1.33
4.31
5.5
5.7
umol/l
10.7
10.7
0.03
433
3707
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
310
2519
1.35
4.27
3.1
3.0
u/l
27.0
29.6
1.94
292
2404
(46235355) HIV 1 and 2 tests - Meaningful Use set
179
1330
1.43
4.22
1.7
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
851
8117
1.72
4.15
15.3
11.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
566
5054
1.32
3.87
3.0
3.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
183
1386
1.40
3.86
1.3
1.3
u/ml
7.5
12.4
0.50
58
556
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
224
1.92
3.74
1.6
1.5
iu/ml
0.2
0.1
—
8
39
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
117
822
1.49
3.69
2.1
2.4
umol/l
5.7
7.2
1.22
96
706
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
188
1444
1.38
3.64
1.3
1.3
iu/ml
23.1
32.1
0.71
52
464
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
51
2.97
3.58
1.9
2.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
168
1270
1.40
3.57
1.6
1.7
nmol/l
1089.0
1213.3
1.11
122
938
(3023323) Follitropin [Units/volume] in Serum or Plasma
69
436
1.63
3.48
1.3
1.3
iu/l
29.4
30.8
0.13
56
380
(3000850) Epithelial cells [#/volume] in Urine
187
1457
1.36
3.29
2.5
2.3
e6/l
6.9
7.2
0.06
151
1277
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
408
3555
1.27
3.10
3.6
3.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
83
565
1.52
3.07
2.3
2.8
g/l
9.9
10.3
0.41
78
528
(3000492) Spirometry study
104
742
1.45
3.05
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
128
951
1.40
3.01
2.0
2.1
ug/g
115.4
112.0
0.03
103
746
(3017732) Neutrophils [#/volume] in Blood
78
527
1.52
2.99
3.3
2.8
e9/l
4.0
3.9
0.12
65
415
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
37
205
1.84
2.99
1.2
1.8
g/l
38.6
38.6
0.01
31
183
(3003327) Ova and parasites identified in Stool by Light microscopy
44
261
1.72
2.85
1.4
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
259
2155
1.28
2.82
2.2
2.0
u/l
160.7
198.8
0.38
236
2031
(3021960) Folate [Moles/volume] in Serum or Plasma
206
1664
1.31
2.81
1.4
1.5
nmol/l
19.9
21.4
0.96
179
1400
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
86
604
1.47
2.75
3.2
3.3
mmol/l
1.2
1.2
1.49
81
510
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
24
118
2.06
2.73
1.0
1.0
u/ml
2.2
2.0
—
7
50
(3026389) Candida sp identified in Specimen by Organism specific culture
20
92
2.20
2.68
1.2
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
38
223
1.73
2.58
1.2
1.9
g/l
0.9
0.9
0.02
32
203
(3009508) Creatinine [Moles/volume] in Urine
261
2197
1.26
2.56
2.8
3.0
mmol/l
7.0
7.2
0.20
222
1849
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
7
7.18
2.55
2.0
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
70
480
1.50
2.53
1.4
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
248
2077
1.27
2.53
1.7
1.6
mmol/l
1.3
1.4
0.54
212
1748
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
115
2.03
2.52
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
57
375
1.55
2.49
1.4
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
206
1690
1.28
2.48
3.1
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
416
3700
1.23
2.45
3.4
3.5
estimate
0.0
0.0
0.00
76
687
(3032080) INR in Blood by Coagulation assay
311
2683
1.24
2.44
8.6
7.5
inr
1.2
1.2
0.20
79
793
(3009261) Glucose [Presence] in Urine by Test strip
422
3761
1.23
2.43
3.4
3.5
estimate
0.0
0.0
0.80
77
666
(3021601) Nitrite [Presence] in Urine by Test strip
418
3724
1.23
2.41
4.9
4.7
estimate
0.0
0.0
0.50
79
690
(3026008) Bacteria identified in Urine by Culture
270
2297
1.25
2.40
3.2
2.9
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
17
4.14
2.36
1.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
78
2.20
2.32
1.2
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
23
3.50
2.27
1.3
2.2
ug/l
38.3
54.8
—
8
23
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
136
1070
1.32
2.24
1.9
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
61
418
1.49
2.24
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
750
7137
1.29
2.23
19.7
13.1
%
39.8
39.6
0.36
595
5242
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
241
1.65
2.23
1.2
1.9
g/l
9.5
10.4
1.02
32
213
(3051651) Icteric interference index of Serum or Plasma
10
36
2.80
2.20
2.0
3.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
243
1.63
2.16
1.2
1.9
g/l
3.0
3.1
0.35
32
198
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
23
124
1.88
2.08
1.7
1.6
—
—
—
0
0
(3019225) pH of Specimen
100
761
1.35
2.07
5.6
3.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
125
1.86
2.04
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
125
1.86
2.04
1.2
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
95
720
1.36
2.02
7.5
6.9
mmol/l
1.2
1.4
0.20
75
577
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
36
224
1.63
2.02
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
110
856
1.32
1.97
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
46
306
1.53
1.97
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
209
1767
1.24
1.93
4.7
4.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
113
1.88
1.93
1.2
1.2
u/ml
3.1
4.2
—
10
33
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
324
1.51
1.92
10.1
9.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
22
121
1.84
1.89
2.0
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
197
1.65
1.89
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
22
3.20
1.88
1.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
9
34
2.66
1.87
1.9
3.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
76
565
1.38
1.84
3.2
4.2
%
0.0
0.8
0.62
15
129
(3022493) Free Hemoglobin [Mass/volume] in Plasma
7
23
3.06
1.80
2.0
7.6
mg/l
102.7
75.0
—
7
14
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
99
770
1.32
1.79
1.2
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
63
457
1.41
1.77
1.6
1.7
g/l
1.3
1.4
0.29
56
430
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
67
2.11
1.76
1.6
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
18
95
1.91
1.76
1.1
1.3
nmol/l
—
—
—
0
0
(3008898) HLA-B27 [Presence]
44
298
1.50
1.76
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
174
1457
1.24
1.76
1.5
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
815
7891
1.31
1.74
5.0
4.7
mmol/l
2.9
2.9
0.28
756
7280
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
37
242
1.55
1.73
1.5
1.6
g/l
0.2
0.2
0.39
32
232
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
24
2.93
1.72
1.0
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
122
982
1.28
1.72
2.5
2.2
g/l
2.4
2.4
0.31
112
906
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
61
2.15
1.72
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
61
2.15
1.72
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
61
2.15
1.72
1.2
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
259
1.53
1.71
1.2
1.9
g/l
4.3
3.8
0.32
31
193
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
259
1.53
1.71
1.2
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
259
1.53
1.71
1.2
1.9
g/l
7.5
7.5
0.03
32
205
(3021440) Promyelocytes/100 leukocytes in Blood
79
599
1.35
1.71
3.5
4.1
%
0.1
0.1
0.57
17
151
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
62
2.11
1.66
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
62
2.11
1.66
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
62
2.11
1.66
1.2
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
25
2.81
1.65
1.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
76
1.99
1.65
1.6
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
264
2319
1.19
1.64
2.7
2.3
u/l
52.7
56.2
1.09
248
2153
(3004588) Protein electrophoresis panel - Serum or Plasma
63
464
1.38
1.64
1.3
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
234
2037
1.20
1.61
2.9
3.2
mg/l
323.5
315.4
0.01
137
1233
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
121
1.75
1.59
1.6
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
34
223
1.54
1.59
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
109
875
1.28
1.58
1.8
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
801
7756
1.27
1.57
4.4
4.3
mmol/l
4.8
4.8
0.12
748
7209
(3017181) Myelocytes/100 leukocytes in Blood
82
634
1.32
1.57
3.5
4.0
%
1.1
1.1
0.03
19
171
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
224
1.54
1.56
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
75
573
1.34
1.56
3.5
3.9
%
0.7
0.6
0.21
15
115
(3004616) Nuclear Ab [Presence] in Serum
16
85
1.90
1.55
1.4
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
64
2.05
1.54
2.7
2.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
115
1.76
1.53
1.3
1.2
u/ml
2.7
5.5
0.60
15
45
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
72
1.96
1.49
1.4
1.2
u/ml
0.1
0.8
—
8
29
(3027135) IgG subclass 1 [Mass/volume] in Serum
13
65
2.01
1.49
1.2
1.3
g/l
6.5
7.1
0.30
13
49
(3024139) IgG subclass 3 [Mass/volume] in Serum
13
65
2.01
1.49
1.2
1.3
g/l
0.5
0.3
0.92
13
49
(3028192) IgG subclass 2 [Mass/volume] in Serum
13
65
2.01
1.49
1.2
1.3
g/l
3.1
2.7
0.29
13
47
(3022217) INR in Platelet poor plasma by Coagulation assay
97
775
1.28
1.47
16.2
20.5
inr
1.3
1.2
0.28
17
106
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
37
252
1.49
1.47
1.5
1.6
g/l
1.1
1.2
0.46
32
239
(42529406) Shigella sp [Presence] in Stool by Culture
34
228
1.51
1.46
1.1
1.2
—
—
—
0
0
(4034850)
14
252
0.55
1.44
10.8
9.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
238
2095
1.18
1.44
1.4
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
22
2.74
1.43
1.2
1.3
—
—
—
0
0
(4211845)
9
39
2.32
1.43
1.9
3.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
72
555
1.32
1.43
1.3
2.7
g/l
66.1
67.3
0.65
63
509
(3009214) Lutropin [Units/volume] in Serum or Plasma
25
157
1.61
1.41
1.3
1.2
u/l
17.1
12.8
0.53
20
125
(3020682) Albumin/Creatinine [Ratio] in Urine
243
2147
1.18
1.40
3.6
3.9
mg/mmol
5.9
6.8
0.21
134
1304
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
91
727
1.28
1.39
1.8
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
198
1720
1.19
1.39
2.0
1.7
mg/l
0.9
1.0
0.56
144
1315
(3034860) Kappa light chains.free [Mass/volume] in Serum
29
190
1.54
1.39
1.4
3.5
mg/l
33.0
41.3
0.63
22
157
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
41
2.21
1.37
1.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
17
2.95
1.36
1.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
59
446
1.35
1.34
1.5
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
91
731
1.27
1.34
3.2
4.1
u/l
233.2
257.1
0.60
83
697
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
72
563
1.30
1.31
2.7
2.8
ug/l
0.7
0.8
0.31
45
342
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
210
1.49
1.29
1.3
1.4
ug/g
263.7
308.3
0.54
18
125
(4062490)
13
69
1.90
1.29
1.2
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
130
1093
1.22
1.29
2.6
2.2
umol/l
13.6
13.1
0.31
120
999
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
39
277
1.43
1.28
1.6
1.7
g/l
1.4
1.5
0.13
29
240
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
48
2.10
1.28
1.1
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
91
736
1.26
1.28
1.9
1.7
—
—
—
0
0
(3020891) Body temperature
15
254
0.58
1.27
3.1
4.3
—
—
—
0
0
(3013512) EKG study
237
2108
1.17
1.25
3.5
3.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
197
1726
1.18
1.25
4.2
3.9
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
36
2.23
1.24
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
54
409
1.34
1.23
1.3
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
96
787
1.25
1.21
1.7
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
117
982
1.22
1.19
2.2
1.8
—
—
—
0
0
(4198724)
6
26
2.32
1.19
1.3
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
26
2.32
1.19
1.0
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
28
190
1.49
1.17
1.4
3.5
mg/l
29.4
45.5
0.50
21
157
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
39
2.06
1.15
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
38
275
1.40
1.15
1.7
1.9
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
20
2.51
1.15
1.0
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
793
7721
1.21
1.14
4.3
4.2
mmol/l
1.5
1.5
0.54
735
7132
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
40
2.01
1.12
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
40
2.01
1.12
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
49
372
1.34
1.12
2.4
2.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
24
160
1.51
1.10
2.0
1.6
e6/l
2657.0
15344.7
2.21
19
124
(3021788) Differential panel - Synovial fluid
19
120
1.60
1.09
1.4
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
108
909
1.21
1.08
2.8
2.3
%
22.1
22.4
0.07
85
773
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
108
910
1.21
1.07
1.8
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
153
1.52
1.07
2.8
3.2
%
60.1
58.3
0.24
23
153
(3023520) Reticulocytes [#/volume] in Blood
67
536
1.27
1.06
2.1
2.4
e9/l
75.1
73.5
0.11
43
407
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
25
170
1.48
1.05
2.8
2.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
49
377
1.32
1.03
1.2
1.6
—
—
—
0
0
(4268621)
13
75
1.74
1.03
2.4
2.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
34
2.07
1.03
1.1
1.1
miu/ml
1540.1
1679.9
—
7
34
(3000991) Gas panel - Venous blood
63
503
1.27
1.02
8.9
7.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
9
48
1.88
1.00
5.3
3.0
nmol/l
76.2
95.8
—
9
48
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
99
1.63
1.00
1.1
1.3
—
—
—
0
0
(4094501)
27
189
1.44
1.00
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
272
0.65
0.99
1.4
1.8
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
9
49
1.84
0.98
1.1
1.4
—
18.0
—
0
9
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
148
1.50
0.98
2.8
3.0
e9/l
4.7
4.2
0.34
22
148
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
9
50
1.81
0.96
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
77
1.70
0.95
1.2
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
51
1.77
0.94
1.6
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
115
989
1.19
0.93
1.2
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
27
2.23
0.93
1.3
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
252
1.36
0.93
1.6
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
35
261
1.35
0.92
1.1
1.3
miu/ml
198.6
236.7
0.24
18
123
(3012544) pH of Venous blood
72
593
1.23
0.91
3.3
3.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
27
193
1.41
0.91
1.2
1.2
—
70.5
—
0
19
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
290
2673
1.12
0.90
2.8
3.3
ng/l
23.9
46.1
0.82
153
1714
(3027945) Reticulocytes/100 erythrocytes in Blood
86
723
1.21
0.90
2.1
2.4
%
1.7
1.8
1.10
81
635
(3034770) Mitochondria Ab [Titer] in Serum
28
203
1.39
0.88
1.2
1.2
—
481.4
—
0
7
(3035320) C reactive protein [Mass/volume] in Body fluid
10
56
1.79
0.88
2.7
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
43
1.87
0.87
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
129
1.48
0.84
1.4
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
129
1.48
0.84
1.0
1.1
u/ml
0.5
1.8
0.68
12
51
(1616796) Gas panel - Central venous blood
8
139
0.57
0.83
6.0
2.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
40
510
0.77
0.83
1.6
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
53
427
1.26
0.83
1.2
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
32
1.88
0.82
1.8
2.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
15
97
1.56
0.81
1.1
2.3
umol/l
5.1
5.5
—
10
66
(3023410) Appearance of Cerebral spinal fluid
14
89
1.58
0.81
1.5
1.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
38
294
1.31
0.81
3.1
3.2
mmol/l
24.8
24.2
0.85
38
265
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
47
1.71
0.80
1.0
1.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
70
584
1.22
0.80
3.0
3.2
mmol/l
2.2
2.1
0.09
42
472
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
207
1.36
0.80
2.3
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
26
190
1.38
0.79
6.0
2.3
%
176.7
179.0
0.05
26
184
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
147
0.61
0.79
1.2
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
33
1.82
0.79
1.5
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
33
1.82
0.79
1.5
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
33
1.82
0.79
1.8
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
33
1.82
0.79
1.5
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
33
1.82
0.79
1.5
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
66
1.67
0.79
2.1
3.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
48
1.67
0.79
1.6
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.0
—
70.6
—
0
5
(1617658) Protocol used for examination of sentinel lymph nodes
5
99
0.50
0.78
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
17
115
1.49
0.77
1.2
1.4
u/ml
331.0
112.7
—
6
24
(3044941) Cell count panel - Synovial fluid
16
107
1.50
0.76
2.0
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
14
208
0.67
0.75
2.3
3.8
mmol/l
3.9
3.8
0.28
14
192
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
133
1.44
0.74
1.0
1.1
u/ml
2.3
3.1
0.32
12
62
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
48
587
0.81
0.73
2.2
2.3
ml/min/173m2
68.0
69.1
0.09
22
228
(40760888) Immunoglobulin light chains.free panel - Serum
20
142
1.42
0.72
1.4
4.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
25
2.01
0.72
1.0
1.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
92
1.53
0.72
2.3
2.5
—
678.4
—
0
8
(3003740) Influenza virus B Ag [Presence] in Specimen
19
134
1.43
0.71
1.0
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
40
1.76
0.71
1.0
1.2
—
10.3
—
0
6
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
169
0.65
0.69
1.4
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
77
1.57
0.68
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
19
261
0.72
0.68
1.4
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
202
1859
1.11
0.65
2.5
2.9
ng/l
1016.2
994.1
0.03
170
1544
(40768797) Stomach Pathology biopsy report
124
1109
1.14
0.64
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
173
1.34
0.62
4.8
2.6
u/ml
0.3
0.4
—
8
93
(3038026) Centromere Ab [Units/volume] in Serum
10
63
1.59
0.62
1.1
1.1
—
83.9
—
0
6
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
96
1.47
0.61
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
50
1.61
0.61
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
51
1.57
0.60
1.1
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
21
0.00
0.60
0.0
2.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
21
0.00
0.60
0.0
1.2
—
4.4
—
0
16
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
21
0.00
0.60
0.0
2.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
109
973
1.14
0.59
4.6
4.6
ug/l
2.7
2.3
0.27
96
862
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
88
774
1.15
0.59
3.6
4.1
%
21.4
21.7
0.08
34
351
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
64
743
0.85
0.59
1.7
1.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
68
587
1.17
0.58
3.0
3.2
kpa
5.6
5.8
1.07
59
573
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
123
1.39
0.58
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
75
653
1.16
0.58
4.8
3.4
—
—
—
0
0
(3036489) Thrombin time
32
256
1.26
0.57
3.7
1.9
s
21.5
21.0
0.31
32
228
(3000093) Morphology [Interpretation] in Blood Narrative
8
55
1.46
0.56
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
65
1.54
0.55
1.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
37
1.63
0.55
1.7
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
37
1.63
0.55
1.5
2.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
38
1.58
0.54
1.5
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
18
134
1.35
0.53
1.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
62
1.46
0.53
1.7
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
62
1.46
0.53
1.7
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
62
1.46
0.53
1.7
1.5
—
—
—
0
0
(4010399)
61
528
1.17
0.52
1.7
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
28
224
1.26
0.51
1.3
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
23
180
1.28
0.50
1.3
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
84
1.43
0.49
1.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
136
1.33
0.49
1.3
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
93
1.40
0.48
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
46
1.53
0.48
2.4
2.1
—
—
—
0
0
(44790048)
11
76
1.45
0.48
2.5
1.5
—
—
—
0
0
(44790047)
11
76
1.45
0.48
2.5
1.5
—
—
—
0
0
(44806118)
11
76
1.45
0.48
2.5
1.5
—
—
—
0
0
(44790049)
11
76
1.45
0.48
2.5
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
47
1.49
0.47
2.9
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
48
1.46
0.47
1.4
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
120
1.34
0.46
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
759
7471
1.09
0.46
3.9
3.8
mmol/l
1.2
1.3
0.48
696
6862
(3018677) aPTT in Platelet poor plasma by Coagulation assay
110
1002
1.11
0.45
3.2
1.9
s
30.7
29.6
0.54
104
971
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
130
1.31
0.44
1.2
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
26
211
1.24
0.44
4.2
2.0
%
94.7
93.7
0.08
26
196
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
202
1.24
0.44
1.5
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
37
313
1.19
0.43
1.1
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
198
1862
1.08
0.42
2.3
2.4
umol/l
6622.6
5347.5
0.13
179
1619
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
149
1.28
0.42
1.0
1.1
u/ml
0.7
2.3
0.86
11
56
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
186
1746
1.08
0.41
1.4
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
13
96
1.36
0.41
1.0
1.1
u/ml
0.0
4.7
—
6
30
(44813793)
8
58
1.38
0.41
1.3
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
33
1.52
0.41
1.2
1.5
nmol/l
97.0
149.1
—
5
33
(3027944) Amphetamines [Presence] in Urine
30
250
1.21
0.40
1.4
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
2.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
18
141
1.28
0.40
2.0
2.0
g/l
132.5
129.3
0.23
13
106
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
34
1.47
0.40
1.2
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
34
1.47
0.40
1.6
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
80
1.38
0.38
1.5
2.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
30
252
1.20
0.38
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
365
0.84
0.37
3.2
3.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
9
68
1.33
0.37
1.6
6.9
mmol/l
9.0
6.9
—
9
53
(3011288) Drugs identified in Urine by Screen method
21
170
1.24
0.37
1.7
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
72
1.39
0.37
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
95
872
1.10
0.36
1.3
1.8
%
1.4
1.4
0.11
83
774
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
77
0.65
0.36
6.0
2.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
162
1.24
0.35
1.9
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
125
0.72
0.35
1.0
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
30
255
1.18
0.34
1.3
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
44
1.37
0.34
1.2
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
218
2076
1.07
0.34
3.4
3.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
60
540
1.12
0.33
1.3
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
46
1.31
0.33
1.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
28
238
1.18
0.32
1.5
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
84
911
0.91
0.31
6.8
6.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
21
175
1.20
0.30
1.3
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
20
166
1.21
0.30
1.3
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
72
660
1.10
0.29
2.2
2.0
g/l
0.2
0.2
0.11
65
622
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
163
0.79
0.29
1.2
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
65
711
0.91
0.29
2.8
4.2
ug/l
11.4
16.4
0.28
51
565
(3037121) Protein [Mass/volume] in Urine
28
241
1.17
0.29
2.3
3.1
g/l
0.1
0.2
1.84
16
85
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
25
213
1.18
0.29
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
213
1.18
0.29
1.2
1.4
—
—
—
0
0
(4281824)
8
109
0.73
0.29
1.3
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
176
1.20
0.29
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
57
1.23
0.29
3.1
2.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
57
1.23
0.29
1.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
130
1.23
0.29
1.9
2.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
94
1.28
0.28
2.3
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
22
186
1.19
0.28
2.3
3.8
u/ml
15.7
33.4
1.76
22
181
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
214
1.17
0.28
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
25
214
1.17
0.28
1.3
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
46
413
1.12
0.28
4.4
4.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
29
253
1.15
0.26
1.4
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
72
0.69
0.26
1.2
3.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
73
0.68
0.26
3.0
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
281
2903
0.95
0.26
2.5
2.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
23
197
1.17
0.26
1.2
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
149
0.80
0.26
1.2
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
72
1.25
0.25
1.2
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
166
1584
1.06
0.25
1.6
1.7
pmol/l
84722647.8
36164192.0
0.37
144
1319
(3028300) Cannabinoids [Presence] in Urine
29
254
1.15
0.25
1.4
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
46
416
1.11
0.25
3.3
3.3
ph
7.4
7.4
—
8
50
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
382
0.89
0.25
1.7
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
22
255
0.86
0.24
1.1
1.4
pmol/l
75.0
220.6
1.43
22
249
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
5
38
1.32
0.23
1.4
2.2
—
447.8
—
0
5
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
92
0.76
0.22
1.6
1.5
—
—
—
0
0
(4306422)
13
107
1.22
0.21
1.2
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
8.0
—
0.3
—
0
11
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
3.8
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.2
—
1.8
—
0
11
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.5
—
12.0
—
0
5
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
3.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806071)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
56.0
—
0
5
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
105
0.76
0.21
1.6
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
5
43
1.16
0.21
2.2
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
43
1.16
0.21
1.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
184
1.14
0.19
1.4
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
68
0.73
0.17
1.0
2.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
329
0.91
0.16
1.7
1.7
mg/l
2.5
4.7
0.61
20
230
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
158
1.14
0.16
1.9
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
206
1.12
0.16
1.1
1.1
—
—
—
0
0
(4146454)
8
72
1.11
0.16
3.8
2.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
73
1.10
0.15
1.3
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
102
1.18
0.15
1.1
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
81
1.11
0.15
1.1
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
81
1.11
0.15
2.8
1.8
pg
32.6
32.1
—
9
81
(3051387) C reactive protein [Mass/volume] in Capillary blood
13
150
0.86
0.14
4.0
3.6
mg/l
34.7
23.8
—
6
92
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
88
0.79
0.14
1.3
2.1
u/ml
6.1
50.9
—
7
81
(3028626) Oxygen [Partial pressure] in Capillary blood
17
150
1.14
0.14
3.1
2.7
kpa
7.7
8.1
0.48
12
143
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
32
295
1.09
0.14
1.5
2.1
u/l
213.5
3759.4
—
10
115
(3022313) Gas panel - Capillary blood
33
305
1.09
0.13
3.9
3.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
199
1.11
0.13
3.1
2.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
56
530
1.06
0.13
2.0
2.3
ug/l
6.3
6.0
0.06
46
468
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
39
365
1.07
0.12
1.3
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
210
1.10
0.12
1.4
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
116
0.86
0.12
2.2
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
69
720
0.95
0.11
3.1
2.9
—
—
—
0
0
(4035726)
70
671
1.05
0.11
1.3
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
86
1.16
0.11
2.1
2.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
115
1.13
0.10
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
193
1970
0.97
0.10
3.8
3.9
estimate
0.0
0.0
0.80
80
681
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
125
1.12
0.10
1.4
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
17
154
1.11
0.10
1.1
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
44
1.14
0.10
1.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
77
798
0.96
0.10
1.3
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
46
1.09
0.09
4.0
4.2
mu/l
32.9
24.1
—
5
46
(3044290) Cell count panel - Cerebral spinal fluid
17
155
1.10
0.09
1.4
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
54
1.11
0.09
3.2
1.7
—
41.0
—
0
9
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
54
1.11
0.09
1.5
1.5
g/l
0.9
1.0
—
6
54
(3006270) Folate [Moles/volume] in Blood
6
54
1.11
0.09
1.0
1.1
nmol/l
335.0
375.6
—
6
48
(3014051) Protein [Presence] in Urine by Test strip
16
175
0.91
0.08
1.6
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
55
572
0.96
0.08
4.2
3.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
64
0.78
0.08
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
117
1.11
0.08
1.6
2.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
205
1.07
0.08
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
87
846
1.03
0.08
2.0
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
78
757
1.03
0.07
1.8
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
133
0.90
0.07
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
71
0.84
0.07
1.0
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
8
75
1.07
0.07
1.9
1.9
pmol/l
154.3
215.0
—
8
70
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
143
0.91
0.07
2.1
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
50
481
1.04
0.07
2.9
2.7
kpa
5.1
4.6
1.14
45
469
(40768795) Lymph node Pathology biopsy report
8
78
1.03
0.07
1.4
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
85
1.06
0.07
1.3
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
87
1.03
0.07
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
101
0.89
0.06
1.0
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
9
104
0.86
0.06
3.8
3.4
nmol/l
1.0
0.8
—
9
81
(3022621) pH of Urine by Test strip
51
493
1.04
0.06
2.3
2.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
119
1.09
0.06
1.6
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
159
1613
0.98
0.05
3.5
3.8
kg/l
1.0
1.0
0.19
22
230
(3020779) Urea [Moles/volume] in Serum or Plasma
55
534
1.03
0.05
8.0
6.5
mmol/l
8.7
8.8
0.04
48
511
(3045424) Erythrocytes [Presence] in Urine
12
110
1.09
0.05
1.5
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
98
963
1.02
0.04
4.7
4.4
%
33.6
32.6
0.38
69
644
(3045414) Leukocytes [Presence] in Urine
31
322
0.96
0.04
1.5
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
71
724
0.98
0.04
1.4
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
289
2910
0.99
0.04
3.7
3.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
40
389
1.03
0.03
1.3
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
41
399
1.03
0.03
3.3
3.2
mmol/l
1.8
1.8
0.02
32
302
(3027273) Bicarbonate [Moles/volume] in Venous blood
30
309
0.97
0.02
2.9
3.1
mmol/l
25.1
25.5
0.34
24
302
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
10
107
0.93
0.02
2.7
1.7
nmol/l
53.6
43.7
—
10
102
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
107
0.93
0.02
1.0
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
14
133
1.05
0.01
3.4
3.8
u/ml
172.2
2669.9
0.74
14
127
(3004119) Hemoglobin [Mass/volume] in Venous blood
39
398
0.98
0.01
3.3
2.9
g/l
133.0
128.3
0.62
34
390
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
193
1.04
0.01
1.6
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
106
0.94
0.01
1.0
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
11
116
0.95
0.00
1.1
1.2
u/l
13.7
19.1
0.47
11
98
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
104
0.96
0.00
1.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
104
0.96
0.00
1.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
104
0.96
0.00
1.0
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
16
164
0.98
0.00
1.9
2.2
ug/min
10.8
96.2
1.85
11
94
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
118
1.02
0.00
2.2
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
17
172
0.99
0.00
1.4
1.6
e6/l
681.3
145.8
0.36
11
136
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
172
0.99
0.00
1.4
1.5
e6/l
11.3
14.7
—
10
133
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
41
408
1.01
0.00
1.4
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
117
1.03
0.00
2.3
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
121
0.99
0.00
1.2
1.2
u/ml
307.3
233.8
—
7
74
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
121
0.99
0.00
1.2
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
119
1.01
0.00
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
34
335
1.02
0.00
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
175
0.97
0.00
5.7
4.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
175
0.97
0.00
1.1
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
105
0.95
0.00
1.0
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
95
0.95
0.00
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
87
0.92
0.00
2.5
1.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
60
1.00
0.00
3.5
1.5
ug/l
18.7
18.6
—
6
60
(3045788) Cell count panel - Pleural fluid
5
50
1.00
0.00
1.4
1.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
7
0.00
0.00
0.0
1.1
—
7.7
—
0
7
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
170
1.00
0.00
1.1
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
61
0.98
0.00
1.5
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
4.9
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
80
1.00
0.00
1.5
2.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
15.4
—
0
5
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
0.0
—
0
6
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
169.0
—
0
5
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
7.7
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
66
0.91
0.00
1.3
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
343.6
—
0
5
(40768441) Liver Pathology biopsy report
6
63
0.95
0.00
1.0
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
9.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
6.5
—
0
7
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.1
—
0
6
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
77
0.91
0.00
1.3
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
57
0.88
0.00
1.2
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
58
0.86
0.00
1.0
2.9
%
14.4
11.1
—
5
58
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
16.2
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: H7_LACRIMALORBITINOTH – Disorders of lacrimal system and orbit in diseases classified elsewhere

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).